Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy
Qiujing Song, Evangelia G. Kranias(University of Cincinnati), Jonathan G. Seidman(Harvard University), Luke Pater(University of Cincinnati), Albrecht Schmidt(Medical University of Graz), Beate Frank, Mike Gerst, Christine E. Seidman(Harvard University), Brian D. Hoit(University Hospitals of Cleveland), Harvey S. Hahn(Brigham and Women's Hospital), Karen Young, Andrew N. Carr(Procter & Gamble (Netherlands)), Gerald W. Dorn(Washington University in St. Louis), Bradley K. McConnell(University of Houston), Kobra Haghighi
Cited by 118
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Cells of the adult human heart
|Nature|2020|1.8k
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k